Not sure if its been said, but what I thought was impressive about the results was that the change from placebo for 4 of the 6 measures showed a linear relationship with increased dose. The change in effect for 70 mg/kg was double the effect for 35 mg/kg for Fragile X Syndrome Rating Scale, Clinical Global Impression, ABC Score and Individual Subject Scorecard. There was no flattening out of efficacy improvement and little concern about safety at the highest dose, leaving a lot of room for greater efficacy at doses higher than 70 mg/kg.
Very encouraging!
- Forums
- ASX - By Stock
- Dose vs efficacy
Not sure if its been said, but what I thought was impressive...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.53 |
Change
0.010(0.06%) |
Mkt cap ! $1.992B |
Open | High | Low | Value | Volume |
$15.75 | $15.80 | $15.37 | $2.703M | 173.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 154 | $15.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.54 | 369 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459 | 15.500 |
7 | 789 | 15.490 |
7 | 894 | 15.480 |
4 | 473 | 15.470 |
3 | 457 | 15.460 |
Price($) | Vol. | No. |
---|---|---|
15.510 | 147 | 7 |
15.520 | 1072 | 14 |
15.530 | 1010 | 13 |
15.540 | 630 | 8 |
15.550 | 459 | 3 |
Last trade - 12.32pm 26/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online